SUVEN LIFE SCIENCES
Back to Income Statement
|
SUVEN LIFE SCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-105 Cr | ₹-118 Cr | ₹-122 Cr | ₹-72 Cr | ₹-94 Cr |
What is the latest Consolidated Net Profit of SUVEN LIFE SCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-105 Cr |
| Mar2024 | ₹-118 Cr |
| Mar2023 | ₹-122 Cr |
| Mar2022 | ₹-72 Cr |
| Mar2021 | ₹-94 Cr |
How is Consolidated Net Profit of SUVEN LIFE SCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-105 Cr | Negative | |
| Mar2024 | ₹-118 Cr | Negative | |
| Mar2023 | ₹-122 Cr | Negative | |
| Mar2022 | ₹-72 Cr | Negative | |
| Mar2021 | ₹-94 Cr | - | |
Compare Consolidated Net Profit of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹5,520.6 Cr | 11% | 53.4% | 60.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | 1% | -6.4% | -0.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 3.5% | 3.4% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,912.0 Cr | 0.2% | -1.8% | 33.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,891.0 Cr | -0.2% | -3.4% | 11.4% | Stock Analytics | |
| CIPLA | ₹99,591.5 Cr | 1.5% | -5.4% | -15.4% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | 11% |
53.4% |
60.1% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses